Central and peripheral forms of C-type natriuretic peptide (CNP): Evidence for differential regulation in plasma and cerebrospinal fluid

Peptides

Volumn 32, Issue 4, 2011, Pages 797-804

  Schouten, Belinda J ^a   Prickett, Timothy C R ^b   Hooper, Ashley A ^b   Hooper, Gary J ^b   Yandle, Timothy G ^b   Richards, A Mark ^b   Espiner, Eric A ^b  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

cGMP; CSF; HPLC; NTproCNP

Indexed keywords

AMINOTERMINAL PRO NATRIURETIC PEPTIDE TYPE C; CYCLIC GMP; MEMBRANE METALLOENDOPEPTIDASE; NATRIURETIC PEPTIDE TYPE C; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, C-TYPE; RADIOIMMUNOASSAY;

EID: 79952815988     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2011.01.013     Document Type: Article

References (52)

1. Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA. Glial and neuronal control of brain blood flow. Nature 2010;468:232-43.
2. Bangsow T, Baumann E, Bangsow C, Jaeger MH, Pelzer B, Gruhn P, et al. The epithelial membrane protein 1 is a novel tight junction protein of the blood-brain barrier. J Cereb Blood Flow Metab 2008;28:1249-60. (Pubitemid 351733349)
3. Bartels CF, Bukulmez H, Padayatti P, Rhee DK, van Ravenswaaij-Arts C, Pauli RM, et al. Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. Am J Hum Genet 2004;75:27-34. (Pubitemid 38801898)
4. Bocciardi R, Giorda R, Buttgereit J, Gimelli S, Divizia MT, Beri S, et al. Overexpression of the C-type natriuretic peptide (CNP) is associated with overgrowth and bone anomalies in an individual with balanced t(2;7) translocation. Hum Mutat 2007;28:724-31. (Pubitemid 47049611)
5. Cao LH, Yang XL. Natriuretic peptides and their receptors in the central nervous system. Prog Neurobiol 2008;84:234-48.
6. Charles CJ, Espiner EA, Richards AM, Nicholls MG, Yandle TG. Biological actions and pharmacokinetics of C-type natriuretic peptide in conscious sheep. Am J Physiol 1995;268:R201-7.
7. Christensen EI, Birn H. Megalin and cubil: multifunctional endocytic receptors. Nat Rev Mol Cell Biol 2002;3:256-66. (Pubitemid 34619261)
8. Chun TH, Itoh H, Ogawa Y, Tamura N, Takaya K, Igaki T, et al. Shear stress augments expression of C-type natriuretic peptide and adrenomedullin. Hypertension 1997;29:1296-302. (Pubitemid 27233180)
9. de Vente J, Markerink-van Ittersum M, Vles JS. ANP-mediated cGMP signaling and phosphodiesterase inhibition in the rat cervical spinal cord. J Chem Neuroanat 2006;31:263-74. (Pubitemid 43668709)
10. Decker JM, Wojtowicz AM, Bartsch JC, Liotta A, Braunewell KH, Heinemann U, et al. C-type natriuretic peptide modulates bidirectional plasticity in hippocampal area CA1 in vitro. Neuroscience 2010;169:8-22.
11. Facchinetti P, Rose C, Schwartz JC, Ouimet T. Ontogeny, regional and cellular distribution of the novel metalloprotease neprilysin 2 in the rat: a comparison with neprilysin and endothelin-converting enzyme-1. Neuroscience 2003;118:627-39. (Pubitemid 36506952)
12. Fernandez-Durango R, Nunez DJ, Brown MJ. Messenger RNAs encoding the natriuretic peptides and their receptors are expressed in the eye. Exp Eye Res 1995;61:723-9. (Pubitemid 26020639)
13. Herman JP, Dolgas CM, Marcinek R, Langub Jr MC. Expression and glucocorticoid regulation of natriuretic peptide clearance receptor (NPR-C) mRNA in rat brain and choroid plexus. J Chem Neuroanat 1996;11:257-65. (Pubitemid 26390718)
14. Herman JP, Dolgas CM, Rucker D, Langub Jr MC. Localization of natriuretic peptide-activated guanylate cyclase mRNAs in the rat brain. J Comp Neurol 1996;369:165-87. (Pubitemid 26152511)
15. Ito S, Ohtsuki S, Katsukura Y, Funaki M, Koitabashi Y, Sugino A, et al. Atrial natriuretic peptide is eliminated from the brain by natriuretic peptide receptor-C-mediated brain-to-blood efflux transport at the blood-brain barrier. J Cereb Blood Flow Metab 2010, doi:10.1038/jcbfm.2010.108.
16. Jiao Y, Yan J, Jiao F, Yang H, Donahue LR, Li X, et al. A single nucleotide mutation in Nppc is associated with a long bone abnormality in lbab mice. BMC Genet 2007;8:16.
17. Johanson CE, Donahue JE, Spangenberger A, Stopa EG, Duncan JA, Sharma HS. Atrial natriuretic peptide: its putative role in modulating the choroid plexus-CSF system for intracranial pressure regulation. Acta Neurochir Suppl 2006;96:451-6.
18. Johanson CE, Duncan 3rd JA, Klinge PM, Brinker T, Stopa EG, Silverberg GD. Multiplicity of cerebrospinal fluid functions: new challenges in health and disease. Cerebrospinal Fluid Res 2008;5:10.
19. Kaneko T, Shirakami G, Nakao K, Nagata I, Nakagawa O, Hama N, et al. C-type natriuretic peptide (CNP) is the major natriuretic peptide in human cerebrospinal fluid. Brain Res 1993;612:104-9. (Pubitemid 23167268)
20. Kishimoto I, Tokudome T, Horio T, Soeki T, Chusho H, Nakao K, et al. C-type natriuretic peptide is a Schwann cell-derived factor for development and function of sensory neurones. J Neuroendocrinol 2008;20:1213-23.
21. Kobayashi H, Ueno S, Tsutsui M, Okazaki M, Uezono Y, Yanagihara N, et al. C-Type natriuretic peptide increases cyclic GMP in rat cerebral microvessels in primary culture. Brain Res 1994;648:324-6.
22. Komatsu Y, Nakao K, Suga S, Ogawa Y, Mukoyama M, Arai H, et al. C-type natriuretic peptide (CNP) in rats and humans. Endocrinology 1991;129:1104-6.
23. Lewis JG, Manley L, Whitlow JC, Elder PA. Production of a monoclonal antibody to cortisol: application to a direct enzyme-linked immunosorbent assay of plasma. Steroids 1992;57:82-5.
24. Luchner A, Schunkert H. Interactions between the sympathetic nervous system and the cardiac natriuretic peptide system. Cardiovasc Res 2004;63:443-9. (Pubitemid 38970188)
25. Minamino N, Aburaya M, Kojima M, Miyamoto K, Kangawa K, Matsuo H. Distribution of C-type natriuretic peptide and its messenger RNA in rat central nervous system and peripheral tissue. Biochem Biophys Res Commun 1993;197:326-35. (Pubitemid 23358915)
26. Moncla A, Missirian C, Cacciagli P, Balzamo E, Legeai-Mallet L, Jouve JL, et al. A cluster of translocation breakpoints in 2q37 is associated with overexpression of NPPC in patients with a similar overgrowth phenotype. Hum Mutat 2007;28:1183-8. (Pubitemid 350250382)
27. Mori Y, Takayasu M, Suzuki Y, Shibuya M, Yoshida J, Hidaka H. Vasodilator effects of C-type natriuretic peptide on cerebral arterioles in rats. Eur J Pharmacol 1997;320:183-6. (Pubitemid 27076744)
28. Muller D, Hida B, Guidone G, Speth RC, Michurina TV, Enikolopov G, et al. Expression of guanylyl cyclase (GC)-A and GC-B during brain development: evidence for a role of GC-B in perinatal neurogenesis. Endocrinology 2009;150:5520-9.
29. Obineche EN, Pathan JY, Fisher S, Prickett TCR, Yandle TG, Frampton CM, et al. Natriuretic peptide and adrenomedullin levels in chronic renal failure and effects of peritoneal dialysis. Kidney Int 2006;69:152-6. (Pubitemid 43117751)
30. Olney RC. C-type natriuretic peptide in growth: a new paradigm. Growth Horm IGF Res 2006;16(Suppl. A):S6-14.
31. Olney RC, Prickett TC, Yandle TG, Espiner EA, Han JC, Mauras N. Amino-terminal propeptide of C-type natriuretic peptide and linear growth in children: effects of puberty testosterone growth hormone. J Clin Endocrinol Metab 2007;92:4294-8. (Pubitemid 350074747)
32. Pagel-Langenickel I, Buttgereit J, Bader M, Langenickel TH. Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy. J Mol Med 2007;85:797-810. (Pubitemid 47077112)
33. Palmer SC, Prickett TC, Espiner EA, Yandle TG, Richards AM. Regional release clearance of C-type natriuretic peptides in the human circulation and relation to cardiac function. Hypertension 2009;54:612-8.
34. Peebles KC, Richards AM, Celi L, McGrattan K, Murrell CJ, Ainslie PN. Human cerebral arteriovenous vasoactive exchange during alterations in arterial blood gases. J Appl Physiol 2008;105:1060-8.
35. Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 2006;27:47-72. (Pubitemid 43228238)
36. Prickett TC, Barrell GK, Wellby M, Yandle TG, Richards AM, Espiner EA. Response of plasma CNP forms to acute anabolic and catabolic interventions in growing lambs. Am J Physiol Endocrinol Metab 2007;292:E1395-400.
37. Prickett TC, Dixon B, Frampton C, Yandle TG, Richards AM, Espiner EA, et al. Plasma amino-terminal pro C-type natriuretic peptide in the neonate: relation to gestational age and postnatal linear growth. J Clin Endocrinol Metab 2008;93:225-32.
38. Prickett TC, Charles CJ, Yandle TG, Richards AM, Espiner EA. Skeletal contributions to plasma CNP forms: evidence from regional sampling in growing lambs. Peptides 2009;30:2343-7.
39. Prickett TCR, Yandle TG, Nicholls MG, Espiner EA, Richards AM. Identification of amino-terminal pro-C-type natriuretic peptide in human plasma. Biochem Biophys Res Commun 2001;286:513-7. (Pubitemid 32912975)
40. Prickett TCR, Lynn AM, Barrell GK, Darlow BA, Cameron VA, Espiner EA, et al. Amino-terminal proCNP: a putative marker of cartilage activity in postnatal growth. Pediatr Res 2005;58:334-40. (Pubitemid 41099883)
41. Prickett TCR, Bothwell JC, Yandle TG, Richards AM, Espiner EA. Pharmacodynamic responses of C-type natriuretic peptide to GH in growth hormone deficient rats: correlation with linear growth. In: Endocrine society's 90th annual meeting conference proceedings. 2010.
42. Rademaker MT, Espiner E. Hormones of the cardiovascular system. In: Jameson JL, De Groot LJ, editors. Endocrinology. 6th ed. Elsevier; 2010. p. 2036-52.
43. Rahmutula D, Gardner DG. C-Type natriuretic peptide down-regulates expression of its cognate receptor in rat aortic smooth muscle cells. Endocrinology 2005;146:4968-74. (Pubitemid 41446636)
44. Rudman D, O'Brien MS, McKinney AS, Hoffman Jr JC, Patterson JH. Observations on the cyclic nucleotide concentrations in human cerebrospinal fluid. J Clin Endocrinol Metab 1976;42:1088-97.
45. Salathe M. Regulation of mammalian ciliary beating. Annu Rev Physiol 2007;69:401-22. (Pubitemid 46457650)
46. Vigne P, Frelin C. C-type natriuretic peptide is a potent activator of guanylate cyclase in endothelial cells from brain microvessels. Biochem Biophys Res Commun 1992;183:640-4.
47. Wei CM, Aarhus LL, Miller VM, Burnett Jr JC. Action of C-type natriuretic peptide in isolated canine arteries and veins. Am J Physiol 1993;264:H71-3.
48. Wellard J, DeVente J, Hamprecht B, Verleysdonk S. Natriuretic peptides, but not nitric oxide donors, elevate levels of cytosolic guanosine 3′,5′-cyclic monophosphate in ependymal cells ex vivo. Neurosci Lett 2006;392:187-92. (Pubitemid 41739622)
49. Wright SP, Prickett TC, Doughty RN, Frampton C, Gamble GD, Yandle TG, et al. Amino-terminal pro-C-type natriuretic peptide in heart failure. Hypertension 2004;43:94-100. (Pubitemid 38031916)
50. Yandle T, Richards M, Smith M, Charles C, Livesey J, Espiner E. Assay of endopeptidase-24.11 activity in plasma applied to in vivo studies of endopeptidase inhibitors. Clin Chem 1992;38:1785-91.
51. Yandle TG, Richards AM, Gilbert A, Fisher S, Holmes S, Espiner EA. Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab 1993;76:832-8. (Pubitemid 23110823)
52. Zhao Z, Ma L. Regulation of axonal development by natriuretic peptide hormones. Proc Natl Acad Sci U S A 2009;106:18016-21.